Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Allergen immunotherapy mechanism refers to the process by which repeated and gradually increasing exposure to a specific allergen leads to immune system desensitization, shifting the immune response towards tolerance, reducing Th2-driven allergic inflammation, increasing regulatory T cell (Treg) activity, and rebalancing antibody profiles from IgE to blocking IgG4. This therapeutic approach modifies the course of IgE-mediated allergic diseases by targeting the immune processes underlying hypersensitivity[1][2][3][4][5][6].
Induction of peripheral tolerance using escalating doses of allergen; Generation of regulatory T cells (Treg/Tr1); Cytokine shift to IL-10, TGF-β; Immunoglobulin isotype switch from IgE to IgG4/IgA; Suppression of mast cell and basophil activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Allergen immunotherapy mechanism.